Key facts
- It has raised $7.1M; the latest was PE Growth/Expansion ($7.1M) in Feb 2026.
- Notable investors include Alkemi Growth Capital, Guwahati Biotech Park, Kotak Alternate Assets Managers.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for ZeroHarm Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for ZeroHarm Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ZeroHarm Sciences
Developer of plant-based formulations intended for health and wellness purposes. The company's platform offers products made from natural ingredients with scientific validation, incorporating traditional knowledge and modern research to address common health concerns such as immunity, stress, digestion, and chronic conditions, enabling health-conscious consumers to access preventive and integrative care through toxin-free alternatives that are suitable for daily use.
- Sector
- Healthcare
- HQ
- Hyderabad, India
- Founded
- 2020
- Employees
- 48
- Website
- zeroharm.in/
- Ownership
- Privately Held (backing)
ZeroHarm Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ZeroHarm Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ZeroHarm Sciences in its N-PORT filings yet. We sweep new filings monthly.